What is Genprex Inc?
, a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company's technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.94M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.